Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2012

Open Access 01-12-2012 | Review

Bacteriophages and their implications on future biotechnology: a review

Authors: Irshad Ul Haq, Waqas Nasir Chaudhry, Maha Nadeem Akhtar, Saadia Andleeb, Ishtiaq Qadri

Published in: Virology Journal | Issue 1/2012

Login to get access

Abstract

Recently it has been recognized that bacteriophages, the natural predators of bacteria can be used efficiently in modern biotechnology. They have been proposed as alternatives to antibiotics for many antibiotic resistant bacterial strains. Phages can be used as biocontrol agents in agriculture and petroleum industry. Moreover phages are used as vehicles for vaccines both DNA and protein, for the detection of pathogenic bacterial strain, as display system for many proteins and antibodies. Bacteriophages are diverse group of viruses which are easily manipulated and therefore they have potential uses in biotechnology, research, and therapeutics. The aim of this review article is to enable the wide range of researchers, scientists, and biotechnologist who are putting phages into practice, to accelerate the progress and development in the field of biotechnology.
Appendix
Available only for authorised users
Literature
1.
Clark JR, March JB: Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol 2006,24(5):212-218. 10.1016/j.tibtech.2006.03.003PubMedCrossRef
2.
Ackerman HW: Tailed bacteriophages: the Caudovirales. Adv Virus Res 1998, 51: 135-201.CrossRef
3.
Inal JM: Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch Immunol Ther Exp 2003,51(4):237-244.
4.
Summers WC: Bacteriophage discovered. In Felix d'Herelle and the Origins of Molecular Biology. Yale University Press; 1999:47-59.
5.
Hermoso JA, Garcia JL, Garcia P: Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Curr Opin Microbiol 2007,10(5):461-472. 10.1016/j.mib.2007.08.002PubMedCrossRef
6.
D'Herelle F, Malone RH, Lahiri MN: Studies on Asiatic cholera. Indian Med Res Mem 1927, 14: 1.
7.
Sulakvelidze A, Kutter E: Bacteriophage therapy in humans. In Bacteriophages: Biology and Applications. Edited by: Kutter E, Sulakvelidze A. CRC Press; 2005:381-436.
8.
Smith HW, Huggins MB: Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 1982,128(2):307-318.PubMed
9.
Summers WC: Bacteriophage therapy. Annu Rev Microbiol 2001, 55: 437-451. 10.1146/annurev.micro.55.1.437PubMedCrossRef
10.
Hausler T: Viruses vs. Superbugs: A Solution to the Antibiotics Crisis?. London: Macmillan; 2007.
11.
12.
Dabrowska K, Switała-Jelen K, Opolski A, Weber-Dabrowska B, Gorski A: Bacteriophage penetration in vertebrates. J Appl Microbiol 2005,98(1):7-13. 10.1111/j.1365-2672.2004.02422.xPubMedCrossRef
13.
Clark JR, March JB: Bacterial viruses as human vaccines? Expert Rev Vaccines 2004,3(4):463-476. 10.1586/14760584.3.4.463PubMedCrossRef
14.
Lo' pez R, Garcı'a E, Garcı'a P: Enzymes for anti-infective therapy: phage lysins. Drug Discov Today Ther Strateg 2004, 1: 469-474. 10.1016/j.ddstr.2004.09.002CrossRef
15.
Fischetti VA: Bacteriophage lytic enzymes: novel anti infectives. Trends Microbiol 2005,13(10):491-496. 10.1016/j.tim.2005.08.007PubMedCrossRef
16.
Borysowski J, Weber-Dabrowska B, Gorski A: Bacteriophage endolysins as a novel class of antibacterial agents. Exp Biol Med 2006,231(4):366-377.
17.
Westwater C, Kasman LM, Schofield DA, Werner PA, Dolan JW, Schmidt MG, et al.: Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections. Antimicrob Agents Chemother 2003,47(4):1301-1307. 10.1128/AAC.47.4.1301-1307.2003PubMedPubMedCentralCrossRef
18.
Smith GP: Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985,228(4705):1315-1317. 10.1126/science.4001944PubMedCrossRef
19.
Sidhu SS: Phage display in pharmaceutical biotechnology. Curr Opin Biotechnol 2000,11(6):610-616. 10.1016/S0958-1669(00)00152-XPubMedCrossRef
20.
Benhar I: Biotechnological applications of phage and cell display. Biotechnol Adv 2001,19(1):1-33. 10.1016/S0734-9750(00)00054-9PubMedCrossRef
21.
Willats WG: Phage display: practicalities and prospects. Plant Mol Biol 2002,50(6):837-854. 10.1023/A:1021215516430PubMedCrossRef
22.
Petrenko VA, Vodyanoy VJ: Phage display for detection of biological threat agents. J Microbiol Methods 2003,53(2):253-262. 10.1016/S0167-7012(03)00029-0PubMedCrossRef
23.
Fernandez-Gacio A, Uguen M, Fastrez J: Phage display as a tool for the directed evolution of enzymes. Trends Biotechnol 2003,21(9):408-414. 10.1016/S0167-7799(03)00194-XPubMedCrossRef
24.
Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR: Making antibodies by phage display technology. Annu Rev Immunol 1994, 12: 433-455. 10.1146/annurev.iy.12.040194.002245PubMedCrossRef
25.
Dickerson TJ, Kaufmann GF, Janda KD: Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy. Expert Opin Biol Ther 2005,5(6):773-781. 10.1517/14712598.5.6.773PubMedCrossRef
26.
Watson BB, Eveland WC: The application of the phage fluorescent antiphage staining system in the specific identification of Listeria monocytogenes. I. Species specificity and immunofluorescent sensitivity of Listeria monocytogenes phage observed in smear preparations. J Infect Dis 1965,115(4):363-369. 10.1093/infdis/115.4.363PubMedCrossRef
27.
Kodikara CP, Crew HH, Stewart GS: Near on-line detection of enteric bacteria using lux recombinant bacteriophage. FEMS Microbiol Lett 1991,67(3):261-265.PubMedCrossRef
28.
Funatsu T, Taniyama T, Tajima T, Tadakuma H, Namiki H: Rapid and sensitive detection method of a bacterium by using a GFP reporter phage. Microbiol Immunol 2002,46(6):365-369.PubMedCrossRef
29.
Hennes KP, Suttle CA, Chan AM: Fluorescently labeled virus probes show that natural virus populations can control the structure of marine microbial communities. Appl Environ Microbiol 1995,61(10):3623-3627.PubMedPubMedCentral
30.
Goodridge L, Chen J, Griffiths M: Development and characterization of a fluorescent-bacteriophage assay for detection of Escherichia coli O157:H7. Appl Environ Microbiol 1999, 65: 1397-1404.PubMedPubMedCentral
31.
Corbitt AJ, Bennion N, Forsythe SJ: Adenylate kinase amplification of ATP bioluminescence for hygiene monitoring in the food and beverage industry. Lett Appl Microbiol 2000,30(6):443-447. 10.1046/j.1472-765x.2000.00744.xPubMedCrossRef
32.
Stewart GSAB, Smith T, Denyer S: Genetic engineering for bioluminescent bacteria. Food Sci Technol Today 1989, 3: 19-22.
33.
Barry MA, Dower WJ, Johnston SA: Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 1996,2(3):299-305. 10.1038/nm0396-299PubMedCrossRef
34.
Dunn IS: Mammalian cell binding and transfection mediated by surface-modified bacteriophage lambda. Biochimie 1996,78(10):856-861. 10.1016/S0300-9084(97)84338-6PubMedCrossRef
35.
Larocca D, Witte A, Johnson W, Pierce GF, Baird A: Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum Gene Ther 1998,9(16):2393-2399. 10.1089/hum.1998.9.16-2393PubMedCrossRef
36.
Larocca D, Kassner PD, Witte A, Ladner RC, Pierce GF, Baird A: Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J 1999,13(6):727-734.PubMed
37.
Hart SL, Knight AM, Harbottle RP, Mistry A, Hunger HD, Cutler DF, et al.: Cell binding and internalization by filamentous phage; displaying a cyclic Arg-Gly-Asp-containing peptide. J Biol Chem 1994,269(17):12468-12474.PubMed
38.
Sperinde JJ, Choi SJ, Szoka FC Jr: Phage display selection of a peptide DNaseII inhibitor that enhances gene delivery. J Gene Med 2001,3(2):101-108. 10.1002/jgm.165PubMedCrossRef
39.
Piersanti S, Cherubini G, Martina Y, Salone B, Avitabile D, Grosso F, et al.: Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain. J Mol Med 2004,82(7):467-476.PubMedCrossRef
40.
Nakanishi M, Eguchi A, Akuta T, Nagoshi E, Fujita S, Okabe J, et al.: Basic peptides as functional components of non-viral gene transfer vehicles. Curr Protein Pept Sci 2003,4(2):141-150. 10.2174/1389203033487234PubMedCrossRef
41.
Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E: Molecular heterogeneity of the vascular endothelium; revealed by in vivo phage display. J Clin Invest 1998,102(7):430-437.PubMedPubMedCentralCrossRef
42.
Ivanenkov VV, Menon AG: Peptide-mediated transcytosis of phage display vectors in MDCK cells. Biochem Biophys Res Commun 2000,276(1):251-257. 10.1006/bbrc.2000.3358PubMedCrossRef
43.
Folgori A, Tafi R, Meola A, Felici F, Galfre G, Cortese R, et al.: A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J 1994,13(9):2236-2243.PubMedPubMedCentral
44.
Phalipon A, Folgori A, Arondel J, Sgaramella G, Fortugno P, Cortese R, Sansonetti PJ, Felici F: Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur J Immunol 1997,27(10):2620-2625. 10.1002/eji.1830271022PubMedCrossRef
45.
Meola A, Delmastro P, Monaci P, Luzzago A, Nicosia A, Felici F, Cortese R, Galfrè G: Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. J Immunol 1995,154(7):3162-3172.PubMed
46.
Irving MB, Pan O, Scott JK: Random-peptide libraries and antigen fragment libraries for epitope mapping and the development of vaccines and diagnostics. Curr Opin Chem Biol 2001,5(3):314-324. 10.1016/S1367-5931(00)00208-8PubMedCrossRef
47.
Wang LF, Yu M: Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr Drug Targets 2004,5(1):1-15.PubMedCrossRef
48.
Molenaar TJ, Michon I, de Haas SA, Van Berkel TJ, Kuiper J, Biessen EA: Uptake and processing of modified bacteriophage M13 in mice: implications for phage display. Virology 2002,293(1):182-191. 10.1006/viro.2001.1254PubMedCrossRef
49.
Kleinschmidt WJ, Douthart RJ, Murphy EB: Interferon production by T4 coliphage. Nature 1970,228(5266):27-30. 10.1038/228027a0PubMedCrossRef
50.
March JB, Clark JR, Jepson CD: Genetic immunization against hepatitis B using whole bacteriophage lambda particles. Vaccine 2004,22(13-14):1666-1671. 10.1016/j.vaccine.2003.10.047PubMedCrossRef
51.
Jepson CD, March JB: Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Vaccine 2004,22(19):2413-2419. 10.1016/j.vaccine.2003.11.065PubMedCrossRef
52.
Clark JR, March JB: Bacteriophage-mediated nucleic acid immunization. FEMS Immunol Med Microbiol 2004,40(1):21-26. 10.1016/S0928-8244(03)00344-4PubMedCrossRef
53.
Curiel TJ, Morris C, Brumlik M, Landry SJ, Finstad K, Nelson A, et al.: Peptides identified through phage display direct immunogenic antigen to dendritic cells. J Immunol 2004,172(12):7425-7431.PubMedCrossRef
54.
McGuire MJ, et al.: A library-selected, Langerhans cell targeting peptide enhances an immune response. DNA Cell Biol 2004,23(11):742-752. 10.1089/dna.2004.23.742PubMedCrossRef
55.
Flaherty JE, Harbaugh BK, Jones JB, Somodi GC, Jackson LE: H-mutant bacteriophages as a potential biocontrol of bacterial blight of geranium. HortSci 2001, 36: 98-100.
56.
Munsch P, Olivier JM: Biocontrol of bacterial blotch of the cultivated mushroom with lytic phages: some practical considerations. Science and cultivation of edible fungi, 2. Proceedings of the 14th International Congress 1995, 595-602.
57.
58.
Sakaguchi I, Shinshima K, Kawaratani K, Sugai O: Control of microbiofouling using bacteriophage 2. Detection of phages and fundamental study of their lytic effect on fouling bacteria. Denryoku Chuo Kenkyusho Hokoku 1989, 1-32.
59.
García P, Rodríguez L, Rodríguez A, Martínez B: Food biopreservation: promising strategies using bacteriocins, bacteriophages and endolysins. Trends Food Sci Technol 2010, 21: 373-382. 10.1016/j.tifs.2010.04.010CrossRef
60.
Goode D, Allen VM, Barrow PA: Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Appl Environ Microbiol 2003,69(8):5032-5036. 10.1128/AEM.69.8.5032-5036.2003PubMedPubMedCentralCrossRef
61.
Modi R, Hirvi Y, Hill A, Griffiths MW: Effect of phage on survival of Salmonella enteritidis during manufacture and storage of cheddar cheese made from raw and pasteurized milk. J Food Prot 2001,64(7):927-933.PubMed
62.
Dykes GA, Moorhead SM: Combined antimicrobial effect of nisin and a listeriophage against Listeria monocytogenes in broth but not in buffer or on raw beef. Int J Food Microbiol 2002,73(1):71-81. 10.1016/S0168-1605(01)00710-3PubMedCrossRef
63.
Leverentz B, Conway WS, Camp MJ, Janisiewicz WJ, Abuladze T, Yang M, Saftner R, Sulakvelidze A: Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Appl Environ Microbiol 2003,69(8):4519-4526. 10.1128/AEM.69.8.4519-4526.2003PubMedPubMedCentralCrossRef
64.
Greer GG, Dilts BD: Control of Brochothrix thermosphacta spoilage of pork adipose tissue using bacteriophages. J Food Prot 2002,65(5):861-863.PubMed
Metadata
Title
Bacteriophages and their implications on future biotechnology: a review
Authors
Irshad Ul Haq
Waqas Nasir Chaudhry
Maha Nadeem Akhtar
Saadia Andleeb
Ishtiaq Qadri
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2012
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-9-9

Other articles of this Issue 1/2012

Virology Journal 1/2012 Go to the issue

Research

Increased titers of neutralizing antibodies after immunization with both envelope proteins of the porcine endogenous retroviruses (PERVs)

Research

Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection

Research

Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblasts

Review

The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review

Research

The antigenic property of the H5N1 avian influenza viruses isolated in central China

Research

Effect of antiviral therapy on the survival and incidence of major complications in HBV-associated cirrhotic patients after splenectomy for hypersplenism and portal hypertension
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits